2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
出版年份 2022 全文链接
标题
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
作者
关键词
-
出版物
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 80, Issue 14, Pages 1366-1418
出版商
Elsevier BV
发表日期
2022-08-26
DOI
10.1016/j.jacc.2022.07.006
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Discordance Between Standard Equations for Determination of LDL Cholesterol in Patients With Atherosclerosis
- (2022) Aparna Sajja et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction
- (2022) Lorenz Räber et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Perioperative Management of Rheumatic Disease and Therapies
- (2021) Diane Zisa et al. MEDICAL CLINICS OF NORTH AMERICA
- Very High Coronary Artery Calcium (CAC ≥ 1000) and Association with CVD Events, Non-CVD Outcomes, and Mortality: Results from The Multi-Ethnic Study of Atherosclerosis (MESA)
- (2021) Allison W. Peng et al. CIRCULATION
- Inclisiran
- (2021) Bruce A. Warden et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study
- (2021) Matthew J. Janik et al. ATHEROSCLEROSIS
- Inhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe Hypertriglyceridemia
- (2021) Zahid Ahmad et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia
- (2021) Salim S. Virani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association
- (2021) Alice H. Lichtenstein et al. CIRCULATION
- Outcomes of a smartphone-based application with live health-coaching post-percutaneous coronary intervention
- (2021) Kaavya Paruchuri et al. EBioMedicine
- Have the Major Cardiovascular Outcomes Trials Impacted Payer Approval Rates for PCSK9 Inhibitors?
- (2020) Ann Marie Navar et al.
- A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia
- (2020) Maureen Sampson et al. JAMA Cardiology
- Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statin-Associated Autoimmune Myopathy: Current Perspectives
- (2020) Eleni Tiniakou Therapeutics and Clinical Risk Management
- Effect of Evolocumab on Atherogenic Lipoproteins During the Peri- and Early Postinfarction Period
- (2020) Thorsten M. Leucker et al. CIRCULATION
- Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: The Coronary Artery Calcium Consortium
- (2020) Albert D. Osei et al. ATHEROSCLEROSIS
- Evinacumab for Homozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction
- (2020) Carl E. Orringer et al. Journal of Clinical Lipidology
- Evinacumab in Patients with Refractory Hypercholesterolemia
- (2020) Robert S. Rosenson et al. NEW ENGLAND JOURNAL OF MEDICINE
- N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
- (2020) Frances A. Wood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term all-cause and cause-specific mortality in asymptomatic patients with CAC ≥ 1000: Results from the Coronary Artery Calcium Consortium
- (2019) Allison W. Peng et al. JACC-Cardiovascular Imaging
- Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
- (2019) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- (2019) Donna K. Arnett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Management of dyslipidemia in adult solid organ transplant recipients
- (2019) Bruce A. Warden et al. Journal of Clinical Lipidology
- Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials
- (2019) Keith C. Ferdinand et al. Journal of Clinical Lipidology
- Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial
- (2019) David M. Charytan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2019 Methodology for Creating Expert Consensus Decision Pathways
- (2019) James L. Januzzi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
- (2019) Christie M Ballantyne et al. European Journal of Preventive Cardiology
- Evolocumab for Early Reduction of LDL-Cholesterol Levels in Patients with Acute Coronary Syndromes (EVOPACS)
- (2019) Konstantinos C. Koskinas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical review on triglycerides
- (2019) Ulrich Laufs et al. EUROPEAN HEART JOURNAL
- Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease
- (2019) Anne C. Goldberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies
- (2019) R. Scott Wright et al. MAYO CLINIC PROCEEDINGS
- Management of Statin Intolerance in 2018: Still More Questions Than Answers
- (2018) Peter P. Toth et al. American Journal of Cardiovascular Drugs
- Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
- (2018) Christie M. Ballantyne et al. ATHEROSCLEROSIS
- High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)
- (2018) Isao Taguchi et al. CIRCULATION
- Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA)
- (2018) Matthew J Budoff et al. EUROPEAN HEART JOURNAL
- A comprehensive review and meta-analysis of risk factors for statin-induced myopathy
- (2018) Khoa A. Nguyen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Managing Incidental Findings on Thoracic CT: Mediastinal and Cardiovascular Findings. A White Paper of the ACR Incidental Findings Committee
- (2018) Reginald F. Munden et al. Journal of the American College of Radiology
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2018) Scott M. Grundy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease
- (2018) Donald M. Lloyd-Jones et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statin-Associated Autoimmune Myopathy
- (2017) Salik Nazir et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- A Test in Context: Lipoprotein(a)
- (2017) Sotirios Tsimikas JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
- (2017) Erin A. Bohula et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
- (2017) Donald M. Lloyd-Jones et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
- (2017) Ajay Gupta et al. LANCET
- Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
- (2017) Robert P Giugliano et al. LANCET
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death
- (2017) John Jeffrey Carr et al. JAMA Cardiology
- 2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?
- (2016) Sripal Bangalore et al. AMERICAN JOURNAL OF MEDICINE
- Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial
- (2016) Maged M. Costantine et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association
- (2016) Barbara S. Wiggins et al. CIRCULATION
- Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia PhenotypeClinical Perspective
- (2016) Amanda M. Perak et al. CIRCULATION
- Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis (MESA)
- (2016) Peter Flueckiger et al. CLINICAL CARDIOLOGY
- Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
- (2016) Dhruv S. Kazi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
- (2016) Donald M. Lloyd-Jones et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
- (2016) Amit V. Khera et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Variability of the LDL-C lowering response to ezetimibe and ezetimibe + statin therapy in hypercholesterolemic patients
- (2015) Olivier Descamps et al. ATHEROSCLEROSIS
- The Agenda for Familial Hypercholesterolemia
- (2015) Samuel S. Gidding et al. CIRCULATION
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
- (2015) Albert Wiegman et al. EUROPEAN HEART JOURNAL
- Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF
- (2015) Matthew J. Feinstein et al. EUROPEAN JOURNAL OF HEART FAILURE
- Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance
- (2015) Paul D. Thompson et al. Journal of Clinical Lipidology
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
- (2015) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statins and congenital malformations: cohort study
- (2015) B. T. Bateman et al. BMJ-British Medical Journal
- Statins and congenital malformations: cohort study
- (2015) B. T. Bateman et al. BMJ-British Medical Journal
- Statin Intolerance
- (2014) Zahid Ahmad AMERICAN JOURNAL OF CARDIOLOGY
- An assessment by the Statin Muscle Safety Task Force: 2014 update
- (2014) Robert S. Rosenson et al. Journal of Clinical Lipidology
- An assessment by the Statin Intolerance Panel: 2014 update
- (2014) John R. Guyton et al. Journal of Clinical Lipidology
- A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
- (2014) Dirk J. Blom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
- (2013) Eliano Pio Navarese et al. AMERICAN JOURNAL OF CARDIOLOGY
- Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile
- (2013) Seth S. Martin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications
- (2013) Seth S. Martin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
- (2013) Robert H. Eckel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
- (2013) David C. Goff et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy of Colesevelam on Lowering Glycemia and Lipids
- (2011) Saurabh Aggarwal et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
- (2011) Anne C. Goldberg et al. Journal of Clinical Lipidology
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Comparison of LDL Cholesterol Concentrations by Friedewald Calculation and Direct Measurement in Relation to Cardiovascular Events in 27 331 Women
- (2009) S. Mora et al. CLINICAL CHEMISTRY
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antioxidative effects of statins
- (2008) Oliver Adam et al. ARCHIVES OF TOXICOLOGY
- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
- (2008) GISSI-HF investigators LANCET
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started